Philippe Chavatte

3.0k citations

85 papers · 2.5k indexed · h-index 26

Impact in

Pharmacology top 2%
- Cannabis and Cannabinoid Research
Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin

Papers in

Pharmacology 28
- Cannabis and Cannabinoid Research 14
- Inflammatory mediators and NSAID effects 10
Biological Psychiatry 3

Co-authors: Amaury Farce Pierre Desreumaux Régis Millet Nicolas Renault Saı̈d Yous Daniel Lesieur Christophe Marot Pascal Berthelot
Journals: Journal of Medicinal Chemistry (16 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (10 papers)European Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Bioorganic & Medicinal Chemistry (4 papers)
Partner nations: France Belgium United Kingdom

In The Last Decade

Philippe Chavatte

85 papers receiving 2.5k citations

Peers

Countries citing papers authored by Philippe Chavatte

Since Specialization

Citations

This map shows the geographic impact of Philippe Chavatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Chavatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Chavatte more than expected).

Fields of papers citing papers by Philippe Chavatte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Chavatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Chavatte. The network helps show where Philippe Chavatte may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Chavatte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Chavatte Line = papers co-authored together Philippe Chavatte links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro PLoS ONE ·Silvia Speca, Caroline Dubuquoy, Christel Rousseaux, Philippe Chavatte, Pierre Desreumaux, Paolo Spagnolo	2021	7
2	Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping European Journal of Medicinal Chemistry ·Wei Tuo, Li-Mei Shi, Natascha Leleu‐Chavain, Mayuresh Balsaraf, Seyyed Jalal Alavian, Xavier Dezitter, Frédérique Klupsch, Brandon A. Strohl, John Spencer, Philippe Chavatte, Régis Millet	2018	16
3	Exploring chiral separation of 3-carboxamido-5-aryl isoxazole derivatives by supercritical fluid chromatography on amylose and cellulose tris dimethyl- and chloromethyl phenylcarbamate polysaccharide based stationary phases Journal of Chromatography A ·Yupeng Xing, Mayuresh Balsaraf, Alina Ghinet, Régis Millet, Philippe Chavatte, Claude Vaccher, Emmanuelle Lipka	2016	7
4	Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate Journal of Enzyme Inhibition and Medicinal Chemistry ·L.J. Lee, Amaury Farce, Karim Bélarbi, Bernard Gressier, Michel Luyckx, Philippe Chavatte, T. Dine	2015	21
5	Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases Current Molecular Pharmacology ·Natascha Leleu‐Chavain, Pierre Desreumaux, Philippe Chavatte, Régis Millet	2014	28
6	Virtual Screening of CB₂ Receptor Agonists from Bayesian Network and High‐Throughput Docking: Structural Insights into Agonist‐Modulated GPCR Features Chemical Biology & Drug Design ·Nicolas Renault, Dave Wyman, Amaury Farce, Jamal El Bakali, Roxane Mansouri, Philippe Gervois, Régis Millet, Pierre Desreumaux, Christophe Furman, Philippe Chavatte	2012	19
7	Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents Current Medicinal Chemistry ·Natascha Leleu‐Chavain, Mathilde Body–Malapel, John Spencer, Philippe Chavatte, Pierre Desreumaux, Régis Millet	2012	31
8	Antioxydant activity of β-carboline derivatives in the LDL oxidation model European Journal of Medicinal Chemistry ·Grant Bender, Kariuki Peter Kinuthia, Françoise Martin‐Nizard, Saı̈d Yous, Sébastien Dilly, Nicolas Lebègue, Philippe Chavatte, Patrick Duriez, Pascal Berthelot, Pascal Carato	2011	17
9	New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis Bioorganic & Medicinal Chemistry ·洸司山下, Giulio G. Muccioli, Mathilde Body–Malapel, Jamal El Bakali, Madjid Djouina, Nicolas Renault, Philippe Chavatte, Pierre Desreumaux, Didier Lambert, Régis Millet	2011	38
10	Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population Gene ·Christian L. Lino Cardenas, Nicolas Renault, Amaury Farce, Christelle Cauffiez, Delphine Allorge, Jean‐Marc Lo‐Guidice, Michel Lhermitte, Philippe Chavatte, Franck Broly, Dany Chevalier	2011	13
11	Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon Proceedings of the National Academy of Sciences ·Laurent Peyrin‐Biroulet, Julia Beisner, Guoxing Wang, Sabine Nuding, محمود أحمد عبد اللطيف, D. F. Kelly, Erika Parmentier-Decrucq, Rodrigue Dessein, Emilie Mérour, Philippe Chavatte, Teddy Grandjean, Aude Bressenot, Pierre Desreumaux, Jean–Frédéric Colombel, Béatrice Desvergne, Eduard F. Stange, Jan Wehkamp, Mathias Chamaillard	2010	161
12	Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands Bioorganic & Medicinal Chemistry ·Christophe Mésangeau, Basile Pérès, Wen Gie Wang, Philippe Chavatte, Valérie Audinot, Ia Stewart, Jean A. Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel H. Caignard, Pascal Berthelot, Saı̈d Yous	2010	23
13	2,6-Diphenylthiazolo[3,2-b][1,2,4]triazoles as telomeric G-quadruplex stabilizers Bioorganic & Medicinal Chemistry Letters ·Jamal El Bakali, Frédérique Klupsch, Aurore Guédin, Albrecht Freiherrn Notthafft, Gaëlle Fontaine, Amaury Farce, Pascal Roussel, Raymond Houssin, Jean‐Luc Bernier, Philippe Chavatte, Jean‐Louis Mergny, Jean‐François Riou, Jean‐Pierre Hénichart	2009	22
14	Characterisation of novel defective thiopurine S-methyltransferase allelic variants Biochemical Pharmacology ·Anne Garat, Christelle Cauffiez, Nicolas Renault, Jean‐Marc Lo‐Guidice, Delphine Allorge, Gh. Mohebali, Nicole Houdret, Philippe Chavatte, Marie‐Anne Loriot, Jean‐Luc Gala, Franck Broly	2008	42
15	Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca2+-activated K+ channel blockers Bioorganic & Medicinal Chemistry Letters ·Amaury Graulich, Sendyvia Candra, Yiding Qin, Sébastien Dilly, Philippe Chavatte, Johan Wouters, Vincent Seutin, Jean‐François Liégeois	2008	15
16	Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds European Journal of Medicinal Chemistry ·ΑΝΝΑ ΤΣΑΝΤΙΛΗ-ΚΑΚΟΥΛΙΔΟΥ, Régis Millet, Raymond Houssin, Mariem Yengui, Amaury Farce, Amélie Lemoine, Jean‐François Goossens, Philippe Chavatte, Nicole Pommery, J.‐P. HENICHART	2006	12
17	Differences in Binding Sites of Two Melatonin Receptors Help to Explain Their Selectivity to Some Melatonin Analogs: A Molecular Modeling Study Journal of Biomolecular Structure and Dynamics ·Anton O. Chugunov, Amaury Farce, Philippe Chavatte, Roman G. Efremov	2006	16
18	Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds Journal of Enzyme Inhibition and Medicinal Chemistry ·Saı̈d Yous, Nicolas Lebègue, H. D. Gunn, Philippe Chavatte, Pascal Berthelot	2005	7
19	Conformation of the tripeptide Cbz‐Pro‐Leu‐Trp‐OBzl(CF₃)₂ deduced from two‐dimensional ¹H‐NMR and conformational energy calculations is related to its affinity for NK₁‐receptor Journal of Peptide Science ·Régis Millet, Laurence Goossens, Jean‐François Goossens, Philippe Chavatte, Xin Li, Raymond Houssin, Jean‐Pierre Hénichart	2001	14
20	Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT4 receptor ligands European Journal of Medicinal Chemistry ·Ousmane Diouf, Patrick Depreux, Philippe Chavatte, Jacques H. Poupaert	2000	14

About Philippe Chavatte

Philippe Chavatte is a scholar working on Pharmacology, Biological Psychiatry, Endocrine and Autonomic Systems, Physiology and Cellular and Molecular Neuroscience, having authored 85 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (15 papers), Cannabis and Cannabinoid Research (14 papers), Receptor Mechanisms and Signaling (14 papers), Inflammatory mediators and NSAID effects (10 papers), Computational Drug Discovery Methods (9 papers), Synthesis and biological activity (8 papers), Circadian rhythm and melatonin (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). The work is most often cited by research in Pharmacology (504 citations), Endocrine and Autonomic Systems (197 citations), Organic Chemistry (707 citations), Molecular Biology (1.2k citations) and Cellular and Molecular Neuroscience (280 citations). Philippe Chavatte has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Amaury Farce, Pierre Desreumaux, Régis Millet, Nicolas Renault, Saı̈d Yous, Daniel Lesieur, Christophe Marot, Pascal Berthelot, Béatrice Desvergne and Natascha Leleu‐Chavain. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact